Valuation: Becton, Dickinson and Company

Market Cap 51.81B 44.47B 41.74B 38.12B 71.94B 4,942B 72.29B 494B 191B 2,493B 195B 190B 8,257B P/E 2026 *
36.7x
P/E 2027 * 20.4x
Enterprise Value 67.7B 58.1B 54.54B 49.81B 94B 6,457B 94.46B 645B 250B 3,257B 254B 249B 10,789B EV / Sales 2026 *
3.51x
EV / Sales 2027 * 3.33x
Free-Float
73.18%
Yield 2026 *
2.06%
Yield 2027 * 2.1%
1 day+0.23%
1 week+1.39%
Current month+14.85%
1 month+21.65%
3 months+28.74%
6 months+7.67%
Current year-1.99%
1 week 186.95
Extreme 186.95
193.07
1 month 161.62
Extreme 161.615
193.07
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
283.5
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap.
8/20/26 Tax

Executive/Senior Manager

-1,049 0.0004%
8/13/26 Fiscal year

Chief Executive Officer

129,834 0.0471%
8/11/26 Sell

EVP and President, EMEA

-2,438 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
+0.23%+1.39%-1.99%-32.07% 51.69B
-1.75%-0.29%-13.29%+9.49% 201B
+0.97%-2.24%-0.17%+11.96% 117B
-0.08%+3.37%+13.15%+82.63% 62.6B
-1.54%-3.29%+27.62%+54.20% 52.49B
-0.22%-1.02%+16.87%-11.71% 33.65B
-2.97%+1.98% - - 31.27B
+0.41%-0.81%+43.12%-11.13% 24.52B
-0.33%+3.70%-3.12%+19.37% 24.05B
+0.14%-0.06%-4.75%+4.58% 23.05B
Average -0.51%+0.13%+8.60%+14.15% 62.09B
Weighted average by Cap. -0.66%-0.32%+1.56%+16.22%

Financials

2026 *2027 *
Net sales 19.29B 16.56B 15.54B 14.19B 26.79B 1,840B 26.92B 184B 71.28B 928B 72.43B 70.86B 3,074B 19.73B 16.94B 15.9B 14.52B 27.4B 1,882B 27.53B 188B 72.91B 949B 74.09B 72.48B 3,145B
Net income 1.44B 1.23B 1.16B 1.06B 1.99B 137B 2B 13.7B 5.31B 69.13B 5.39B 5.28B 229B 2.34B 2.01B 1.88B 1.72B 3.25B 223B 3.26B 22.3B 8.64B 113B 8.78B 8.59B 373B
Net Debt 15.88B 13.63B 12.8B 11.69B 22.06B 1,515B 22.16B 151B 58.69B 764B 59.64B 58.35B 2,532B 13.95B 11.97B 11.24B 10.27B 19.37B 1,331B 19.47B 133B 51.55B 671B 52.38B 51.25B 2,223B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-08-26 $190.21 +0.23% 1,403,112
26-08-25 $189.78 -0.50% 1,207,516
26-08-24 $190.74 -0.66% 1,310,993
26-08-21 $192.00 +2.33% 2,524,521
26-08-20 $187.62 +0.01% 1,972,683
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
190.21USD
Average target price
194.42USD
Spread / Average Target
+2.21%

Quarterly revenue - Rate of surprise